Fig. 6 | Signal Transduction and Targeted Therapy

Fig. 6

From: Molecular classification of hormone receptor-positive /HER2-positive breast cancer reveals potential neoadjuvant therapeutic strategies

Fig. 6

Analysis of agreement between immunohistochemistry (IHC)-based classification and mRNA-based classification. a Immunohistochemical staining criteria for the four factors CD8A, KRT5, GFRA1, PFKP (negative, weak positive, strong positive, scale bar 100 µm); the bar graph on the right represents the percentage of positivity for the factor in each subtype. b HR+/HER2+ breast cancer classification method based on IHC. c Agreement between IHC-based classification and mRNA-based classification for each subtype

Back to article page